title: A topical matter: toxic epidermal necrolysis.
authors.affiliation: Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Electronic address: barryladizinski@gmail.com.
authors.forename: Barry
authors.initials: B
authors.lastname: Ladizinski
authors.affiliation: Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
authors.forename: Christopher
authors.initials: C
authors.lastname: Sankey
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D004890:Erythema / Q000139:chemically induced* / Q000175:diagnosis; D005909:Glioblastoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D000077287:Levetiracetam; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000627:therapeutic use; D010098:Oxycodone / Q000009:adverse effects / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D000077204:Temozolomide; D014945:Wound Healing; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000701:Analgesics, Opioid; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000932:Antiemetics; D000970:Antineoplastic Agents; D004338:Drug Combinations; D007155:Immunologic Factors; D010880:Piperidines; D054328:Proton Pump Inhibitors; D011799:Quinazolines; D005719:gamma-Globulins; C514822:oxycodone-acetaminophen; D000082:Acetaminophen; D000077287:Levetiracetam; D003606:Dacarbazine; D003907:Dexamethasone; D010098:Oxycodone; D009853:Omeprazole; D008775:Methylprednisolone; D000077204:Temozolomide; C452423:vandetanib; D010889:Piracetam